Browse the evidence

Combining GLP-1 based therapies (GBTs) with individualized nutritional and physical activity interventions is necessary to preserve lean muscle mass, mitigate gastrointestinal adverse effects, and optimize long-term weight management outcomes.

When starting a GLP-1 medication like Ozempic or Wegovy, do not rely on the drug alone. You must actively manage your diet and exercise. Aim for 1.2 to 1.5 grams of protein per kilogram of your body weight every day, and engage in resistance training (weight lifting) at least twice a week alongside 150 minutes of moderate cardio. If you experience nausea, eat smaller, more frequent meals and stay hydrated. This combination prevents muscle loss and helps you stick with the treatment.

A structured, telehealth-based Individualized Virtual Integrative Medicine (IVIM) protocol combined with semaglutide (branded or compounded) significantly enhances weight loss outcomes, achieving an average 19.5% total body weight reduction at 52 weeks.

If you have obesity and are using semaglutide, sticking to a structured care plan that includes regular medical check-ins, coaching, and app-based tracking can lead to significant weight loss (approx. 20% over a year). This holds true whether you use the branded version or a compounded version, provided you maintain continuous therapy without gaps. The key is adherence and managing side effects through professional support.

To preserve skeletal muscle mass during obesity treatment with obesity medications (OMs) or caloric restriction, patients should consume 0.8 g/kg/day of high-quality protein (minimum 60-80 g/day), with higher requirements (1.0-1.5 g/kg/day) for older adults and those with chronic diseases.

If you are losing weight with medication or diet, prioritize protein. Aim for 0.8 grams of protein per kilogram of your body weight daily, or at least 60-80 grams. If you are older or have chronic health conditions, aim higher (1.0-1.5 g/kg). Combine this with resistance exercise to protect your muscle.

Integrating GLP-1 receptor agonist therapy with intermittent fasting and protein-optimized resistance training preserves lean mass and improves metabolic outcomes more effectively than either intervention alone.

Start GLP-1 therapy as prescribed to manage appetite. Use this reduced hunger to gradually adopt time-restricted eating (e.g., 16:8). Prioritize high-protein meals during your eating window and engage in resistance training 2-3 times per week to protect muscle. This combination aims to maximize fat loss while minimizing muscle loss and long-term drug costs.

Combining GLP-1 pharmacotherapy with promyogenic agents (e.g., bimagrumab, enobosarm), structured resistance exercise, and targeted nutrition (protein/HMB) mitigates lean mass loss and improves functional outcomes compared to GLP-1 monotherapy.

Do not rely on GLP-1 medication alone. To protect your muscles and strength, you must combine your medication with resistance exercise, ensure you are eating enough protein, and ask your doctor about emerging combination therapies like promyogenic agents that specifically target muscle preservation.

A holistic primary care model combining carbohydrate reduction (targeting <130 g/day), health coaching, and community support significantly reduces HbA1c and achieves diabetes reversal or remission in patients with type 2 diabetes and prediabetes.

To manage type 2 diabetes or prediabetes, reduce your daily carbohydrate intake to below 130 grams, focusing on whole foods. Engage with a health coach for behavioral support and join community groups for peer encouragement. Monitor your HbA1c regularly with your doctor, and be prepared for potential medication adjustments as your blood sugar improves. This approach has been shown to reverse diabetes in a significant portion of patients in real-world settings.

Weight loss is significantly associated with greater HbA1c reduction in patients following a carbohydrate-reduced diet.

Losing weight will significantly improve your blood sugar levels. For every kilogram you lose, your HbA1c is expected to drop by approximately 0.56 mmol/mol. Focus on sustainable weight loss through the carbohydrate-reduced diet and health coaching.

Phenotype-guided interventions (tailoring diet, medication, or exercise based on specific metabolic/behavioral traits like satiation or emotional eating) result in greater weight loss compared to non-phenotype-guided standard care.

Consider getting assessed for specific metabolic and behavioral traits (like how you feel after eating, your emotional triggers, or your resting metabolic rate). Tailoring your diet and medication choices to these specific traits may lead to significantly better weight loss results than following a generic plan.

Achieving a BMI <25 kg/m2 is associated with a significantly greater reduction in predicted 10-year atherosclerotic cardiovascular disease (ASCVD) risk compared to maintaining a BMI ≥25 kg/m2, regardless of whether the weight loss is achieved via tirzepatide or placebo.

If you have obesity or overweight, aiming for a BMI below 25 kg/m2 may offer greater protection against heart disease and stroke than stopping at a smaller weight loss. This target is increasingly achievable with modern medications like tirzepatide, which help achieve significant weight reduction. While current guidelines suggest 5-15% weight loss, this analysis indicates that reaching a 'normal' BMI might provide additional cardiovascular benefits, particularly for those with existing risk factors like high blood pressure or NAFLD.

Combined aerobic and resistance exercise provides additive or synergistic benefits for MASLD by simultaneously enhancing oxidative metabolism and increasing skeletal muscle mass.

For the best results, combine aerobic exercise (like brisk walking or cycling) with resistance training (like weight lifting). Aim for 150-300 minutes of moderate aerobic activity and 2-3 resistance sessions per week. This combination targets both your liver's fat processing and your muscle's ability to use energy, providing a comprehensive metabolic benefit.

High-level natural bodybuilders optimize muscle hypertrophy during pre-contest preparation by performing approximately 8–17 direct weekly sets per muscle group, training each muscle group 2–3 times per week, and utilizing a primary repetition range of 6–10 reps performed to or near failure.

If you are a natural trainee aiming for muscle growth, aim for 8 to 17 hard sets per muscle group each week. Split these sets across 2 or 3 training sessions for that muscle (e.g., chest on Monday and Thursday). Use weights that allow you to complete your reps with only 0-4 reps left in the tank. This moderate volume is what elite natural competitors use to maximize muscle while managing recovery.

A structured, physiotherapy-led eHealth tier 2 weight management program (12 weeks, 60 mins/week) significantly reduces body weight and BMI in adults with obesity, with effects observed across diverse ethnic and socioeconomic groups.

If you have obesity and are referred to a structured 12-week digital weight management program by your doctor, you can expect to lose an average of 3-4 kg (about 4% of body weight) if you complete the program. The program includes weekly 1-hour online sessions with a physiotherapist, combining exercise and nutrition education. It works for people of all ethnicities and income levels, but you need internet access and a device. The key to success is attending at least 75% of the sessions.

Whole-food, nutrient-dense diets that reduce ultra-processed food consumption are effective for weight management and metabolic health.

Focus on eating whole, nutrient-dense foods and minimize ultra-processed foods. This approach supports weight management and metabolic health through energy balance, hormonal regulation, and gut microbiota effects.

High-protein diets (25-30% of calories) preserve lean muscle mass and improve metabolic parameters like insulin sensitivity during weight loss.

Increase protein intake to 25-30% of your daily calories to preserve muscle and improve metabolic health. Ensure you consume high-quality protein sources and balance with carbs and fats.

Engagement with a digital weight management platform (coaching, app use, weight tracking) significantly enhances weight loss outcomes in individuals using GLP-1 or GLP-1/GIP receptor agonists compared to pharmacotherapy alone.

If you are using GLP-1 or GLP-1/GIP medications for weight loss, actively engaging with your digital health platform (attending coaching, using the app, tracking weight) leads to significantly better results than just taking the medication. Aim to participate in coaching sessions, log your weight regularly, and use the app's educational features to maximize your weight loss.

A multimodal metabolic health intervention emphasizing therapeutic carbohydrate reduction (TCR) and intermittent fasting, supported by remote monitoring and coaching, produces robust 1-year weight loss (mean 15.5%) and significant medication deprescription in patients with obesity and type 2 diabetes.

If you have obesity or type 2 diabetes, consider a structured program that combines a low-carbohydrate diet (under 30g carbs/day) with remote health monitoring and coaching. This approach can lead to significant weight loss (around 15%) and may allow you to reduce or stop diabetes and blood pressure medications under medical supervision, potentially saving money and avoiding medication side effects.

High-Intensity Interval Training (HIIT) is more effective for fat loss and muscle retention in younger obese adults (18-30 years), whereas Moderate-Intensity Continuous Training (MICT) is preferred for middle-aged (31-40) and older (41-60) adults due to better adherence and sustainability.

If you are under 30 and obese, HIIT may offer faster fat loss and muscle retention. If you are over 30, prioritize Moderate-Intensity Continuous Training (MICT) like brisk walking or cycling, as it is equally effective for fat loss but easier to stick with and safer for joints.

HIIT is more time-efficient than MICT for achieving similar fat loss outcomes, primarily due to excess post-exercise oxygen consumption (EPOC) and appetite regulation.

If you are short on time, HIIT can provide similar fat loss benefits to longer cardio sessions in less time, thanks to increased calorie burn after exercise.

A structured 12-week calorie-restricted dietary intervention starting with a 6-week Very Low-Calorie Diet (VLCD) phase (800-1200 kcal/day) followed by a 6-week maintenance phase significantly reduces body weight and improves postprandial glycemic response in Korean adults with early type 2 diabetes and obesity.

For Korean adults with early type 2 diabetes and obesity, a structured 12-week program starting with a 6-week very low-calorie diet (800-1200 kcal/day, with meals provided) followed by a 6-week self-managed maintenance phase can lead to significant weight loss (approx. 7-8%) and improved blood sugar control. The key is the structured, phased approach and meal provision to ensure adherence.

Short-term provision of Healthy Ketogenic Diet Ready-To-Eat (HKD-RTE) meals enhances initial weight loss and adherence compared to HKD counseling alone, leading to sustained greater weight reduction at 6 months despite the RTE intervention ending after one month.

If you struggle with the time and effort of preparing a ketogenic diet, try using ready-to-eat meals that fit your macros for the first month. This study suggests that this short-term convenience can help you establish better habits and lose more weight in the long run (6 months) compared to just getting advice. Focus on getting the first month right with convenient, pre-made meals to build momentum.

Adherence to Healthy Ketogenic Diet Ready-To-Eat (HKD-RTE) meals is positively associated with greater weight loss, with each 1% increase in compliance linked to additional weight loss over 3 months.

Your weight loss is directly tied to how consistently you follow the meal plan. Even small improvements in your compliance (like eating your pre-made meals more often) can lead to extra weight loss. Don't aim for perfection; aim for consistency, as every bit of compliance counts.

Nutritional guidance that dynamically adjusts energy intake based on regular measurements of Resting Energy Expenditure (REE) and physical activity effectively reduces body weight in patients with obesity without triggering metabolic adaptation (REE reduction) or increasing hunger.

To lose weight without triggering your body's survival mechanisms (slowed metabolism and intense hunger), you must tailor your calorie intake to your specific energy burn. This involves measuring your Resting Energy Expenditure (REE) and tracking physical activity, then adjusting your daily calorie target regularly (e.g., weekly) as your body changes. Use technology like meal-tracking apps to ensure you are hitting these dynamic targets. This personalized approach allows for significant weight loss (approx. 5% in 24 weeks) while keeping your metabolism and hunger levels stable.

Combining High-Intensity Interval Training (HIIT) with Resistance Training (RT) increases lean muscle mass and reduces visceral fat more effectively than Moderate-Intensity Continuous Training (MICT) alone in postmenopausal women.

If you are a postmenopausal woman looking to lose visceral fat and build muscle, combine short, intense cardio intervals with resistance training 3 times a week instead of just doing steady-state cardio.

Both 5:2 and 16:8 intermittent fasting protocols produce statistically significant weight loss in overweight and obese individuals over a 6-week period, with no statistically significant difference in efficacy between the two methods.

If you are overweight or obese, you can choose either the 5:2 method (eating very little on 2 days a week) or the 16:8 method (eating within an 8-hour window daily) to lose weight. Both work significantly over 6 weeks, and neither is proven to be better than the other. Pick the one you can stick with consistently.